3M Biotech Co., Ltd

Based on technology,Create the future.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsSex Steroid Hormone

CAS 630-56-8 Progesterone Hormone , 17 Hydroxyprogesterone Caproate For Women

CAS 630-56-8 Progesterone Hormone , 17 Hydroxyprogesterone Caproate For Women

CAS 630-56-8 Progesterone Hormone , 17 Hydroxyprogesterone Caproate For Women

Product Details:

Place of Origin: China
Brand Name: Rund
Certification: ISO9001
Model Number: CAS 630-56-8

Payment & Shipping Terms:

Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: 10/100/250/500/1000g/foil bag
Delivery Time: 2-3 days
Payment Terms: T/T, Western Union, MoneyGram, BTCcoin
Supply Ability: 1000kg per momth
Contact Now
Detailed Product Description
Product Name: 17a-Hydroxyprogesterone Caproate CAS: 630-56-8
Appearance: White Powder MF: C27H40O4
MW: 428.6 Assay: 99%

Progesterone Hormones 17a-Hydroxyprogesterone Caproate CAS 630-56-8 White Powder
 
Details

 

Product name 17a-Hydroxyprogesterone caproate
Synonyms PREGN-4-ENE-3,20-DIONE HEXANOATE
CAS 630-56-8
MF C27H40O4
MW 428.6
EINECS 211-138-8
Product Categories Biochemistry;Hydroxyketosteroids;Steroids;Steroid and Hormone ; Hormone Drugs
M.S. Progesterone Hormones 17a-Hydroxyprogesterone Caproate CAS 630-56-8
MP 119°C
Purity 99%
Package 10g/100g/1000g/foil bag
Dispatch time Within 5 work days after confirming your payment
Delivery time 4~6 working days after confirming your payment
Payment terms Western Union , Moneygram , T/T , Bitcoin
Delivery terms EMS , DHL , TNT , FEDEX , UPS

 

Description

 

17α-Hydroxyprogesterone caproate is a synthetic steroid hormone that is similar to medroxyprogesterone acetate and megestrol acetate. It is an ester derivative of 17α-hydroxyprogesterone formed from caproic acid (hexanoic acid).
 

17α-Hydroxyprogesterone caproate was previously marketed under the trade name Delalutin by Squibb, which was approved by the U.S. Food and Drug Administration (FDA) in 1956 and withdrawn from marketing in 1999.
 

The US FDA approved Makena from KV Pharmaceutical (previously named as Gestiva) on February 4, 2011 for prevention of preterm delivery in women with a history of preterm delivery, sparking a pricing controversy.

 

Application

 

This medication is used in women who are pregnant with a single baby, and who have delivered a baby too early (preterm) in the past. It is used to help lower the risk of having a preterm baby again. Hydroxyprogesterone is a man-made form of a female hormone (progestin). It is not known how it works to prevent preterm labor.
 

This medication is not intended to prevent preterm birth in women pregnant with more than one baby (such as twins, triplets). It is also not intended to stop active preterm labor.

 

Specification

 

Items Standard Resutls
Description White or almost white crystalline powder, odorless Conforms
Solubility insoluble in water, solube in ether, slightly soluble in benzene Conforms
Specific Optical Rotation +58°---+64° (1% chloroform Solution) 60.3°
Melting Point about 120 -124 ℃ 123℃
Water ≤0.1% 0.05%
Free N-Caproic Acid ≤0.58% 0.20%
Ordinary Impurities ≤2.0% conforms
Residual Solvents Methanol ≤ 3000PPM 1280PPM
Ethanol≤5000PPM 1500PPM
Dichloromethane ≤ 600PPM 80PPM
Assay 97.0%--103.0% 99.30%
Conclusion

Conforms to USP31

 

Contact Details
3M Biotech Co., Ltd

Contact Person: Mr. Dr. Zhang

Send your inquiry directly to us (0 / 3000)